The immunological effect of revaccination with Bacille Calmette-Guérin vaccine at 19 months of age

Vaccine

Volumn 31, Issue 17, 2013, Pages 2137-2144

  Andersen, Andreas ^a,b   Roth, Adam ^b,c   Jensen, Kristoffer Jarlov ^a,b   Erikstrup, Christian ^d   Lisse, Ida Marie ^e   Whittle, Hilton ^f   Sartono, Erliyani ^g   Yazdanbakhsh, Maria ^g   Aaby, Peter ^a,b   Benn, Christine Stabell ^a,b  

^a STATENS SERUM INSTITUT   (Denmark)

^b Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Guinea-Bissau)

^c LUND UNIVERSITY   (Sweden)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^f MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BCG; DTP booster; Immunology; Micronutrients; Non specific effects

Indexed keywords

BCG VACCINE; CYTOKINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; TRACE ELEMENT; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BCG VACCINATION; BLOOD CULTURE; BLOOD SAMPLING; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIPHTHERIA; DRUG EFFICACY; FEMALE; GEOMETRIC MEAN RATIO; GEOMETRY; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TETANUS; TUBERCULOSIS;

BCG VACCINE; CONFIDENCE INTERVALS; DIETARY SUPPLEMENTS; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; GUINEA-BISSAU; HUMANS; IMMUNIZATION, SECONDARY; INFANT; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-13; LIPOPOLYSACCHARIDES; MALE; MICRONUTRIENTS; MYCOBACTERIUM BOVIS; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION;

EID: 84875842014     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.02.050     Document Type: Article

References (39)

1. Roth A., Garly M.L., Jensen H., Nielsen J., Aaby P. Bacillus Calmette-Guerin vaccination and infant mortality. Expert Rev Vaccines 2006 Apr, 5(2):277-293.
2. Shann F. The non-specific effects of vaccines. Arch Dis Child 2010 Sep, 95(9):662-667.
3. Biering-Sorensen S., Aaby P., Napirna B.M., Roth A., Ravn H., Rodrigues A., et al. Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guerin vaccination at first health center contact. The Pediatric infectious disease journal 2012 Mar, 31(3):306-308.
4. Aaby P., Roth A., Ravn H., Napirna B.M., Rodrigues A., Lisse I.M., et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?. The Journal of infectious diseases 2011 Jul 15, 204(2):245-252.
5. Aaby P., Garly M.L., Nielsen J., Ravn H., Martins C., Bale C., et al. Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: Observations from vaccination trials in Guinea-Bissau. Pediatr Infect Dis J 2007 Mar, 26(3):247-252.
6. Aaby P., Jensen H., Gomes J., Fernandes M., Lisse I.M. The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study. Int J Epidemiol 2004, 33(2):374-380.
7. Aaby P., Jensen H., Samb B., Cisse B., Sodemann M., Jakobsen M., et al. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies. Lancet 2003, 361(9376):2183-2188.
8. Aaby P., Benn C.S., Nielsen J., Lisse I.M., Rodrigues A., Ravn H. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open 2012, 2.
9. Roth A.E., Benn C.S., Ravn H., Rodrigues A., Lisse I.M., Yazdanbakhsh M., et al. Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau. BMJ 2010, 340:c671.
10. Benn C.S., Martins C., Rodrigues A., Ravn H., Fisker A.B., Christoffersen D., et al. The effect of vitamin A supplementation administered with missing vaccines during national immunization days in Guinea-Bissau. Int J Epidemiol 2009, 38(1):304-311.
11. Rodrigues A., Schellenberg J.A., Roth A., Benn C.S., Aaby P., Greenwood B. Revaccination with Bacillus Calmette-Guerin (BCG) vaccine does not reduce morbidity from malaria in African children. Tropical Medicine & International Health 2007, 12(2):224-229.
12. Martins C.L., Garly M.L., Bale C., Rodrigues A., Ravn H., Whittle H.C., et al. Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial. BMJ 2008, 337(jul24 2):a661-a670.
13. Roth A., Sodemann M., Jensen H., Poulsen A., Gustafson P., Gomes J., et al. Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000-2002. Vaccine 2005 Jun 10, 23(30):3991-3998.
14. Tobin J. Estimation of Relationships for Limited Dependent Variables. Econometrica 1958, 26(1):24-36.
15. Andersen A, Benn CS, Jorgensen MJ, Ravn H. Censored correlated cytokine concentrations: multivariate Tobit regression using clustered variance estimation. Statistics in medicine 2012 Dec 5.
16. Rasmussen J., Andersen A., Fisker A.B., Ravn H., Sodemann M., Rodrigues A., et al. Mid-upper-arm-circumference and mid-upper-arm circumference z-score: the best predictor of mortality?. Eur J Clin Nutr 2012 Sep, 66(9):998-1003.
17. Kristensen I., Aaby P., Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 2000 Dec 9, 321(7274):1435-1438.
18. Stensballe L.G., Nante E., Jensen I.P., Kofoed P.E., Poulsen A., Jensen H., et al. Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study. Vaccine 2005 Jan 26, 23(10):1251-1257.
19. Kleinnijenhuis J., Quintin J., Preijers F., Joosten L.A., Ifrim D.C., Saeed S., et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A 2012 Sep 17.
20. Madura Larsen J., Benn C.S., Fillie Y., van der Kleij D., Aaby P., Yazdanbakhsh M. BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro. Immunology 2007 Jun, 121(2):276-282.
21. Ota M.O., Vekemans J., Schlegel-Haueter S.E., Fielding K., Sanneh M., Kidd M., et al. Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J Immunol 2002 Jan 15, 168(2):919-925.
22. Akkoc T, Aydogan M, Yildiz A, Karakoc-Aydiner E, Eifan A, Keles S, et al. Neonatal BCG vaccination induces IL-10 production by CD4+ CD25+ T cells. Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology 2010 Nov;21(7):1059-63.
23. Barbosa T., Arruda S., Fernandes B.D., Carvalho L.P., Cardoso S., Cunha S., et al. BCG (Bacille of Calmette-Guerin) revaccination leads to improved in vitro IFN-gamma response to mycobacterial antigen independent of tuberculin sensitization in Brazilian school-age children. Vaccine 2003 May 16, 21(17-18):2152-2160.
24. Hanekom W.A. The immune response to BCG vaccination of newborns. Ann NY Acad Sci 2005 Dec, 1062:69-78.
25. Lalor M.K., Floyd S., Gorak-Stolinska P., Ben-Smith A., Weir R.E., Smith S.G., et al. BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. The Journal of infectious diseases 2011 Oct 1, 204(7):1075-1085.
26. Mendez-Samperio P., Trejo A., Perez A. Mycobacterium bovis Bacillus Calmette-Guerin (BCG) stimulates IL-10 production via the PI3K/Akt and p38 MAPK pathways in human lung epithelial cells. Cell Immunol 2008 Jan, 251(1):37-42.
27. Nadler R., Luo Y., Zhao W., Ritchey J.K., Austin J.C., Cohen M.B., et al. Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guerin (BCG) mediated antitumour activity. Clin Exp Immunol 2003 Feb, 131(2):206-216.
28. Smith S.G., Lalor M.K., Gorak-Stolinska P., Blitz R., Beveridge N.E., Worth A., et al. Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining. BMC immunology 2010, 11:35.
29. Jason J., Archibald L.K., Nwanyanwu O.C., Kazembe P.N., Chatt J.A., Norton E., et al. Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring. Infect Immun 2002 Nov, 70(11):6188-6195.
30. Ozera A., Tukenmezb F., Biricika A., Barlanb I., Cirakoglua B., Basarana M. Effect of BCG accination on cytokine mRNA expression in atopic children with asthma. Immunol Lett 2003, 86:29-35.
31. Lalor M.K., Ben-Smith A., Gorak-Stolinska P., Weir R.E., Floyd S., Blitz R., et al. Population differences in immune responses to BCG in infancy. J Infect Dis 2009, 199(6):795-800.
32. Marchant A., Goetghebuer T., Ota M.O., Wolfe I., Ceesay S.J., De Groote D., et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol 1999 Aug 15, 163(4):2249-2255.
33. Diness B.R., Fisker A.B., Roth A., Yazdanbakhsh M., Sartono E., Whittle H., et al. Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guerin vaccine. The American journal of clinical nutrition 2007 Oct, 86(4):1152-1159.
34. Burl S., Adetifa U.J., Cox M., Touray E., Ota M.O., Marchant A., et al. Delaying bacillus Calmette-Guerin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J Immunol 2010 Aug 15, 185(4):2620-2628.
35. Djuardi Y., Sartono E., Wibowo H., Supali T., Yazdanbakhsh M. A longitudinal study of BCG vaccination in early childhood: the development of innate and adaptive immune responses. PloS one 2010, 5(11):e14066.
36. Elliott A.M., Mawa P.A., Webb E.L., Nampijja M., Lyadda N., Bukusuba J., et al. Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation. Vaccine 2010 Dec 16, 29(2):247-255.
37. Malhotra I., Mungai P., Wamachi A., Kioko J., Ouma J.H., Kazura J.W., et al. Helminth- and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol 1999 Jun 1, 162(11):6843-6848.
38. Anderson E.J., Webb E.L., Mawa P.A., Kizza M., Lyadda N., Nampijja M., et al. The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda. Vaccine 2012 Mar 9, 30(12):2083-2089.
39. Ritz N., Dutta B., Donath S., Casalaz D., Connell T.G., Tebruegge M., et al. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial. Am J Respir Crit Care Med 2012 Jan 15, 185(2):213-222.